Exit
Register
Login
2025 MaTOS Lung | Session II | Early-Stage Resectable Lung Cancer
Complete Pathologic Response and Other Surrogates to Evaluate Success of Neoadjuvant Therapy?
Surgical Outcomes of Perioperative Therapy in the Era of Immunotherapy
Debate: In 2025, Is Perioperative Immunotherapy the New Standard of Care? (Yes)
Debate: In 2025, Is Perioperative Immunotherapy the New Standard of Care? (No)
How To Identify Those Patients Who Need Adjuvant Therapy?
Q & A Session
Finish Course
You need to enroll in this course to view this chapter
This chapter is locked
Debate: In 2025, Is Perioperative Immunotherapy the New Standard of Care? (No)
Enroll for $5,000.00
0% Course Complete